HuGE Literature Finder
|
||
Records 1-13
|
Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention.
Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saeidi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
|
The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study.
Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
|
Gene polymorphism of CYP2C19*2, *3 and CYP3A4*1B and early stent thrombosis: case reports and literature review.
Personalized medicine 2016 Sep 13 (5): 423-428. Kulmyrzaeva Nazgul, Tatarunas Vacis, Skipskis Vilius, Smagulova Gaziza, Seitmaganbetova Nazgul, Veikutiene Audrone, Lesauskaite Vai |
|
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.
Acta pharmacologica Sinica 2016 May . Liu Rui, Zhou Zi-Yi, Chen Yi-Bei, Li Jia-Li, Yu Wei-Bang, Chen Xin-Meng, Zhao Min, Zhao Yuan-Qi, Cai Ye-Feng, Jin Jing, Huang M |
|
Cytochrome allelic variants and clopidogrel metabolism in cardiovascular diseases therapy.
Molecular biology reports 2016 Apr . Jarrar Mohammed, Behl Shalini, Manyam Ganiraju, Ganah Hany, Nazir Mohammed, Nasab Reem, Moustafa Khal |
|
PPARA gene and phenprocoumon: a new predictor of response variability.
Pharmacogenetics and genomics 2015 Feb 25 (2): 93-5. Botton Mariana R, Bandinelli Eliane, Leiria Tiago L L, Rohde Luis E P, Hutz Mara |
|
Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
|
The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
|
Amlodipine, clopidogrel and CYP3A5 genetic variability: effects on platelet reactivity and clinical outcomes after percutaneous coronary intervention.
Heart (British Cardiac Society) 2012 Sep 98 (18): 1366-72. Park Kyung Woo, Kang Jeehoon, Park Jin Joo, Yang Han-Mo, Lee Hae-Young, Kang Hyun-Jae, Koo Bon-Kwon, Oh Byung-Hee, Park Young-Bae, Kim Hyo-S |
Human metabolic individuality in biomedical and pharmaceutical research.
Nature 2011 Sep 477 (7362): 54-60. Suhre Karsten, Shin So-Youn, Petersen Ann-Kristin, Mohney Robert P, Meredith David, Wägele Brigitte, Altmaier Elisabeth, , Deloukas Panos, Erdmann Jeanette, Grundberg Elin, Hammond Christopher J, de Angelis Martin Hrabé, Kastenmüller Gabi, Köttgen Anna, Kronenberg Florian, Mangino Massimo, Meisinger Christa, Meitinger Thomas, Mewes Hans-Werner, Milburn Michael V, Prehn Cornelia, Raffler Johannes, Ried Janina S, Römisch-Margl Werner, Samani Nilesh J, Small Kerrin S, Wichmann H-Erich, Zhai Guangju, Illig Thomas, Spector Tim D, Adamski Jerzy, Soranzo Nicole, Gieger Christi |
|
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study.
European heart journal 2010 Dec 31 (24): 3046-53. Harmsze Ankie M, van Werkum Jochem W, Ten Berg Jurriën M, Zwart Bastiaan, Bouman Heleen J, Breet Nicoline J, van 't Hof Arnoud W J, Ruven Hendrik J T, Hackeng Christian M, Klungel Olaf H, de Boer Anthonius, Deneer Vera H |
|
Perioperative genomic profiles using structure-specific oligonucleotide probes.
Clinical medicine & research 2009 Sep 7 (3): 69-84. Hogan Kirk J, Burmester James K, Caldwell Michael D, Hogan Quinn H, Coursin Douglas B, Green Dawn N, Selzer Rebecca M R, Broderick Thomas P, Rusy Deborah A, Poroli Mark, Lutz Anna L, Sanders Allison M, Oldenburg Mary C, Koelbl James A, de Arruda-Indig Monika, Halsey Jennifer L, Day Stephen P, Domanico Michael |
|
Impact of CYP2C19 Polymorphisms on the Antiplatelet Effect of Clopidogrel in an Actual Clinical Setting in Japan.
Circulation journal : official journal of the Japanese Circulation Society 2009 Jun . Jinnai T, Horiuchi H, Makiyama T, Tazaki J, Tada T, Akao M, Ono K, Hoshino K, Naruse Y, Takahashi K, Watanabe H, Kita T, Kimura T |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 15, 2019
- Content source: